GLOBAL PH Share Price

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - OTC Markets 01:29:56 06/06/2026 am IST 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for GLOBAL PH -.--% +60.20%
3 months+60.20%
6 months+60.20%

Valuation: GLOBAL PH

Market Cap 47.23L 41.27L 38.09L 35.11L 66.17L 45Cr 67.64L 4.55Cr 1.79Cr 22Cr 1.77Cr 1.73Cr 77Cr P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 20.42L 17.84L 16.46L 15.18L 28.6L 20Cr 29.24L 1.97Cr 77.4L 9.63Cr 76.67L 74.99L 33Cr EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
3 months+60.20%
6 months+60.20%
Current year+60.20%
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.08
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 23.76L 20.76L 19.16L 17.66L 33.28L 23Cr 34.02L 2.29Cr 90.06L 11Cr 89.21L 87.25L 39Cr 28.19L 24.64L 22.73L 20.95L 39.5L 27Cr 40.37L 2.72Cr 1.07Cr 13Cr 1.06Cr 1.04Cr 46Cr
Net income -12.34L -10.79L -10L -9L -17.29L -12Cr -17.68L -1.19Cr -46.8L -5.82Cr -46.36L -45.34L -20Cr -32.99L -28.83L -26.6L -24.52L -46.22L -32Cr -47.24L -3.18Cr -1.25Cr -16Cr -1.24Cr -1.21Cr -54Cr
Net Debt -2.68 -2.34 -2.16 -1.99 -3.75 -257.94 -3.84 -25.82 -10.15 -126.33 -10.06 -9.84 -434.88 -2.68 -2.34 -2.16 -1.99 -3.76 -258.2 -3.84 -25.84 -10.16 -126.46 -10.07 -9.85 -435.32
Logo GLOBAL PH
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
217
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock